A comparative efficacy trial in Germany in which infants received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) vaccine or DT vaccine.
Stehr
K
K
Universitätsklinik für Kinder and Jugendliche, Erlangen, Germany.
Cherry
J D
JD
D002985:Clinical Protocols; D015331:Cohort Studies; D004168:Diphtheria Toxoid; D022422:Diphtheria-Tetanus Vaccine; D015721:Diphtheria-Tetanus-Pertussis Vaccine; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D004311:Double-Blind Method; D005858:Germany; D006801:Humans; D007223:Infant; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D013745:Tetanus Toxoid; D017778:Vaccines, Combined; D014917:Whooping Cough / Q000517:prevention & control*
D004168:Diphtheria Toxoid; D022422:Diphtheria-Tetanus Vaccine; D015721:Diphtheria-Tetanus-Pertussis Vaccine; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D013745:Tetanus Toxoid; D017778:Vaccines, Combined